Report Categories
View AllRecent Articles
View All
What the market is pricing into Protara Therapeutics TARA ahead of earnings Q4 2025 Profit Disappoints
FHB First Hawaiian posts narrow Q4 2025 EPS beat shares dip slightly amid muted investor reaction
The inflation impact visible in Femasys FEMY results Q4 2025 EPS Tops Views
ICMB Investcorp reports wide Q3 2025 earnings miss as shares edge higher on favorable investor sentiment
COYA Coya stock climbs almost four percent despite reporting wider than expected Q4 2025 per share losses
RNA Atrium Therapeutics revenue surges 708 in Q1 but shares slip as losses persist
What vTv Therapeutics VTVT is doing to expand margins Q4 2025 Profit Exceeds Views
What Georgia GPJA disclosed about cash conversion GPJA Q3 Earnings Georgia Subordinated Notes Interest on Track
Does CBRE Group CBRE stock offer a good entry point Q1 2026 Profit Exceeds Views
Is ScanSource SCSC stock cheap relative to fundamentals Q1 2026 EPS Misses Estimates
TBH Brag House posts Q4 loss of 116 per share missing estimates by 1335 percent shares fall 44 percent
ECBK ECB Bancorp dips 088 in daily trading following release of its Q4 2025 quarterly earnings results